NovoCure Limited (NVCR)
NASDAQ: NVCR
· Real-Time Price · USD
17.44
0.79 (4.74%)
At close: May 08, 2025, 3:59 PM
17.83
2.24%
After-hours: May 08, 2025, 05:46 PM EDT
4.74% (1D)
| Bid | 16.5 |
| Market Cap | 1.94B |
| Revenue (ttm) | 621.71M |
| Net Income (ttm) | -164.19M |
| EPS (ttm) | -1.51 |
| PE Ratio (ttm) | -11.55 |
| Forward PE | -7.88 |
| Analyst | Buy |
| Ask | 19.16 |
| Volume | 575,891 |
| Avg. Volume (20D) | 907,949 |
| Open | 16.96 |
| Previous Close | 16.65 |
| Day's Range | 16.85 - 17.70 |
| 52-Week Range | 14.17 - 34.13 |
| Beta | 0.73 |
About NVCR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVCR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVCR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-12.43%
NovoCure shares are trading lower after the compan...
Unlock content with
Pro Subscription
4 months ago
+11.14%
NovoCure shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $28 to $42.
